SEC Form 4 · accession 0001415889-15-000758

Cocrystal Pharma, Inc. · COCP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director · 10% Owner

Period of report

Mar 3, 2015

Accepted (ET)

Mar 5, 2015 · 4:28 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001412486

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Mar 3, 2015	M	269,114,822	—	A	269,114,822	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series A Convertible Preferred Stock^F1	—	Mar 3, 2015	M	789,747	D	—	—	Common Stock	269,114,822	0	D

F1Each share of Series A Convertible Preferred Stock held by the reporting person was automatically convertible for no additional consideration into 340.760802 shares of the issuer's common stock at such time as the issuer obtained sufficient authorized capital. The issuer filed a charter amendment increasing its authorized common stock with the Secretary of State of Delaware on March 3, 2015, which caused the automatic conversion of the Series A Convertible Preferred Stock into common stock. The Series A Convertible Preferred Stock had no expiration date.